# RGNX (REGENXBIO Inc.) - SEC EDGAR Financial Statements

> REGENXBIO Inc. reported $153.9M in revenue and a net loss of $175.2M for the trailing twelve months ended September 30, 2026 (down 69.2% year over year), with a -95.7% operating margin.

- Canonical: https://convexityos.com/fundamentals/RGNX
- Markdown: https://convexityos.com/fundamentals/RGNX.md
- SEC CIK: 0001590877
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:36 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001590877&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $153.9M | -69.2% YoY |
| Operating Income | TTM | -$147.3M | -95.7% margin |
| Net Income | TTM | -$175.2M | -113.9% net margin |
| Diluted EPS | TTM | -$2.69 | Split-adjusted |
| Free Cash Flow | TTM | -$154.8M | -100.6% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $251.0M | Total debt: $66.55M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $170.4M | $83.33M | $90.24M | $112.7M | $470.3M | $154.6M | $35.23M | $218.5M | $10.39M | $4.59M |
| Cost of Revenue | -- | $33.57M | $37.21M | $54.55M | $51.83M | $35.71M | $8.24M | $9.64M | $1.71M | $98K |
| **Gross Profit** | -- | $49.76M | $53.03M | $58.18M | $418.5M | $118.9M | $26.99M | $208.9M | $8.68M | $4.49M |
| Research & Development | $228.3M | $208.5M | $232.3M | $242.5M | $181.4M | $166.3M | $124.2M | $83.87M | $57.22M | $45.48M |
| **Operating Income** | -$161.2M | -$233.3M | -$268.1M | -$262.9M | $160.0M | -$119.2M | -$149.0M | $88.10M | -$75.89M | -$65.34M |
| **EBITDA** | -$145.6M | -$217.1M | -$250.8M | -$250.0M | $169.5M | -$110.8M | -$141.8M | $92.08M | -$73.20M | -$64.80M |
| Interest Income | $12.20M | $12.10M | $9.10M | $5.50M | -- | -- | -- | -- | -- | -- |
| Interest Expense | $45.01M | $12.66M | $6.86M | $23.25M | $26.28M | $771K | -- | -- | -- | -- |
| Income Before Tax | -$193.9M | -$227.1M | -$263.6M | -$280.4M | $141.2M | -$106.0M | -$97.49M | $104.1M | -$73.17M | -$63.40M |
| Income Tax Expense | $0 | $0 | -$152K | -$84K | $13.41M | $5.24M | -$2.75M | $4.18M | $0 | -$435K |
| **Net Income** | -$193.9M | -$227.1M | -$263.5M | -$280.3M | $127.8M | -$111.2M | -$94.73M | $99.94M | -$73.17M | -$62.97M |
| Basic EPS | -$3.76 | -$4.59 | -$6.02 | -$6.50 | $3.01 | -$2.98 | -$2.58 | $2.99 | -$2.45 | -$2.38 |
| **Diluted EPS** | -$3.76 | -$4.59 | -$6.02 | -$6.50 | $2.91 | -$2.98 | -$2.58 | $2.73 | -$2.45 | -$2.38 |
| Basic Shares Outstanding | 51.6M | 49.5M | 43.7M | 43.2M | 42.4M | 37.3M | 36.7M | 33.4M | 29.9M | 26.4M |
| Diluted Shares Outstanding | 51.6M | 49.5M | 43.7M | 43.2M | 43.9M | 37.3M | 36.7M | 36.6M | 29.9M | 26.4M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $9.16M | $108.0M | $6.39M | $30.34M | $29.73M | $21.36M | $89.01M | $21.21M |
| Cost of Revenue | -- | -- | -- | -- | -- | -- | -- | $6.32M |
| **Gross Profit** | -- | -- | -- | -- | -- | -- | -- | $14.90M |
| Research & Development | $61.01M | $56.09M | $57.34M | $59.61M | $56.10M | $59.50M | $53.09M | $50.38M |
| **Operating Income** | -$35.53M | $29.26M | -$83.36M | -$57.64M | -$52.41M | -$63.28M | $12.13M | -$51.37M |
| **EBITDA** | -$32.02M | $33.02M | -$79.50M | -$53.77M | -$48.52M | -$59.37M | $16.08M | -$47.34M |
| Interest Income | $2.30M | $1.20M | $2.00M | $2.80M | $3.60M | $3.40M | $2.50M | $2.90M |
| Interest Expense | $7.47M | $7.79M | $8.71M | $12.28M | $13.17M | $10.99M | $8.57M | $9.42M |
| **Net Income** | -$40.74M | $22.71M | -$90.05M | -$67.15M | -$61.94M | -$70.87M | $6.08M | -$51.19M |
| Basic EPS | -$0.62 | $0.43 | -$1.72 | -- | -$1.20 | -$1.38 | $0.12 | -- |
| **Diluted EPS** | -$0.62 | $0.43 | -$1.72 | -- | -$1.20 | -$1.38 | $0.12 | -- |
| Basic Shares Outstanding | 65.3M | 52.8M | 52.4M | -- | 51.7M | 51.5M | 51.4M | -- |
| Diluted Shares Outstanding | 65.3M | 53.0M | 52.4M | -- | 51.7M | 51.5M | 51.4M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $34.47M | $57.53M | $34.52M | $96.95M | $345.2M | $338.4M | $69.51M | $75.56M | $46.66M | $24.84M |
| Short-Term Investments | $195.6M | $177.2M | $240.7M | $267.7M | $112.2M | $137.3M | $226.7M | $244.2M | $114.1M | $64.71M |
| **Cash & Short-Term Investments** | $240.9M | $244.9M | $314.1M | $565.2M | $849.3M | $522.5M | $400.0M | $470.6M | $176.4M | $159.0M |
| Accounts Receivable, Net | $26.38M | $20.47M | $24.79M | $28.08M | $32.44M | $43.00M | $38.15M | $31.60M | $5.85M | -- |
| Other Current Assets | $12.90M | $13.77M | $20.40M | $9.35M | $10.20M | $1.95M | $4.20M | $3.83M | $1.41M | $1.01M |
| **Total Current Assets** | $281.3M | $278.0M | $335.0M | $416.0M | $518.8M | $531.2M | $345.0M | $337.9M | $168.0M | $93.37M |
| Property, Plant & Equipment, Net | $104.9M | $117.6M | $132.1M | $141.7M | $131.5M | $56.47M | $28.97M | $28.70M | $13.98M | $9.32M |
| Long-Term Investments | $10.79M | $10.18M | $38.87M | $200.6M | $391.9M | $46.81M | $103.8M | $150.8M | $15.62M | $69.41M |
| Other Non-Current Assets | $4.61M | $4.00M | $4.81M | $6.40M | $6.43M | $5.28M | $4.55M | $2.31M | $862K | $400K |
| **Total Non-Current Assets** | $171.8M | $188.0M | $239.0M | $417.3M | $595.1M | $177.0M | $152.9M | $205.9M | $30.68M | $79.36M |
| **Total Assets** | $453.0M | $466.0M | $574.0M | $833.3M | $1.11B | $708.2M | $497.9M | $543.8M | $198.7M | $172.7M |
| Accounts Payable | $21.36M | $22.80M | $22.79M | $27.21M | $11.39M | $10.62M | $6.41M | $4.41M | $4.83M | $1.54M |
| Deferred Revenue (Current) | $10.45M | $115K | $148K | $1.83M | $3.33M | $449K | -- | $600K | -- | -- |
| **Total Current Liabilities** | $118.1M | $103.2M | $130.3M | $130.4M | $130.5M | $81.45M | $33.68M | $22.18M | $14.44M | $9.67M |
| Deferred Revenue (Non-Current) | $18.94M | -- | -- | -- | -- | $3.78M | $3.33M | $3.33M | -- | -- |
| Other Non-Current Liabilities | $638K | $3.63M | $6.25M | $8.83M | $745K | $524K | $1.83M | $2.50M | -- | -- |
| **Total Non-Current Liabilities** | $232.2M | $103.1M | $132.0M | $186.6M | $219.1M | $249.0M | $14.04M | $12.79M | $1.21M | $1.33M |
| **Total Liabilities** | $350.3M | $206.3M | $262.2M | $317.1M | $349.6M | $330.4M | $47.71M | $34.97M | $15.65M | $10.99M |
| **Total Debt (incl. Leases)** | $73.50M | $82.03M | $89.29M | $94.80M | $86.68M | $72.65M | $11.29M | $5.85M | -- | -- |
| Common Stock | $5.0K | $5.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K | $3.0K |
| Retained Earnings | -$1.13B | -$932.1M | -$705.0M | -$441.6M | -$161.2M | -$289.1M | -$177.8M | -$83.02M | -$187.8M | -$114.6M |
| Accumulated Other Comp. Income | -$687K | -$741K | -$4.43M | -$15.40M | -$2.57M | -$360K | $205K | -$720K | -$715K | -$33K |
| **Total Stockholders' Equity** | $102.7M | $259.7M | $311.7M | $516.2M | $764.3M | $377.8M | $450.2M | $508.8M | $183.0M | $161.7M |
| Total Equity | $102.7M | $259.7M | $311.7M | $516.2M | $764.3M | $377.8M | $450.2M | $508.8M | $183.0M | $161.7M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $95.80M | $36.49M | $15.23M | $34.47M | $58.80M | $79.56M | $130.1M | $57.53M |
| Short-Term Investments | $155.2M | $69.03M | $135.3M | $195.6M | $215.4M | $243.7M | $137.8M | $177.2M |
| **Cash & Short-Term Investments** | $251.0M | $105.5M | $150.5M | $240.9M | $302.0M | $363.6M | $272.7M | $244.9M |
| Accounts Receivable, Net | $8.54M | $106.8M | $10.04M | $26.38M | $25.35M | $20.20M | $18.19M | $20.47M |
| Other Current Assets | $48.15M | $11.76M | $14.44M | $12.90M | $19.47M | $19.48M | $16.08M | $13.77M |
| **Total Current Assets** | $320.9M | $236.2M | $186.5M | $281.3M | $332.0M | $373.8M | $313.2M | $278.0M |
| Property, Plant & Equipment, Net | $95.35M | $98.45M | $101.9M | $104.9M | $107.5M | $111.0M | $114.5M | $117.6M |
| Long-Term Investments | -- | -- | -- | $10.79M | $27.84M | $40.30M | $4.86M | $10.18M |
| Other Non-Current Assets | $5.30M | $5.90M | $5.51M | $4.61M | $4.27M | $1.88M | $2.99M | $4.00M |
| **Total Non-Current Assets** | $145.1M | $150.5M | $155.4M | $171.8M | $193.2M | $207.3M | $177.7M | $188.0M |
| **Total Assets** | $466.0M | $386.6M | $341.9M | $453.0M | $525.2M | $581.0M | $490.9M | $466.0M |
| Accounts Payable | $13.48M | $15.55M | $21.21M | $21.36M | $22.27M | $21.66M | $19.04M | $22.80M |
| Deferred Revenue (Current) | $5.99M | $9.88M | $5.92M | $10.45M | $13.20M | $13.98M | $13.59M | $115K |
| **Total Current Liabilities** | $67.68M | $82.62M | $71.11M | $118.1M | $124.6M | $119.5M | $106.7M | $103.2M |
| Deferred Revenue (Non-Current) | $16.22M | $15.40M | $22.78M | $18.94M | $21.19M | $23.80M | $26.30M | -- |
| Other Non-Current Liabilities | $475K | $486K | $622K | $638K | $648K | $664K | $680K | $3.63M |
| **Total Non-Current Liabilities** | $250.3M | $232.2M | $249.7M | $232.2M | $239.2M | $247.8M | $110.0M | $103.1M |
| **Total Liabilities** | $318.0M | $314.9M | $320.8M | $350.3M | $363.8M | $367.3M | $216.7M | $206.3M |
| **Total Debt (incl. Leases)** | $66.55M | $68.95M | $71.07M | $73.50M | $76.51M | $77.70M | $79.85M | $82.03M |
| Common Stock | $7.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K |
| Retained Earnings | -$1.23B | -$1.19B | -$1.22B | -$1.13B | -$1.06B | -$996.9M | -$926.1M | -$932.1M |
| Accumulated Other Comp. Income | -$1.04M | -$875K | -$870K | -$687K | -$652K | -$750K | -$762K | -$741K |
| **Total Stockholders' Equity** | $148.0M | $71.77M | $21.08M | $102.7M | $161.5M | $213.7M | $274.2M | $259.7M |
| Total Equity | $148.0M | $71.77M | $21.08M | $102.7M | $161.5M | $213.7M | $274.2M | $259.7M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$193.9M | -$227.1M | -$263.5M | -$280.3M | $127.8M | -$111.2M | -$94.73M | $99.94M | -$73.17M | -$62.97M |
| Depreciation & Amortization | $15.62M | $16.21M | $17.32M | $12.91M | $9.56M | $8.41M | $7.15M | $3.98M | $2.69M | $544K |
| Stock-Based Compensation | $34.56M | $38.46M | $40.27M | $40.79M | $38.81M | $31.95M | $26.85M | $16.64M | $10.61M | $7.03M |
| Change in Receivables | -$7.66M | $9.71M | $3.94M | $4.82M | $14.12M | -$9.90M | -$8.62M | -$16.80M | $561K | $1.07M |
| Change in Payables | -$2.28M | -$292K | -$2.79M | $18.79M | -$2.30M | $3.87M | $1.53M | -$218K | $2.62M | $186K |
| **Operating Cash Flow** | -$124.0M | -$173.1M | -$218.4M | -$207.5M | $218.9M | -$54.06M | -$107.7M | $104.6M | -$57.99M | -$48.56M |
| Capital Expenditure | -$2.41M | -$2.44M | -$9.96M | -$30.72M | -$84.17M | -$26.87M | -$11.72M | -$13.28M | -$7.16M | -$8.15M |
| **Free Cash Flow** | -$126.4M | -$175.6M | -$228.4M | -$238.2M | $134.7M | -$80.93M | -$119.4M | $91.37M | -$65.15M | -$56.71M |
| Purchases of Investments | -$332.6M | -$190.1M | -$86.56M | -$184.9M | -$498.1M | -$123.0M | -$190.7M | -$445.8M | -$68.63M | -$45.07M |
| **Investing Cash Flow** | -$15.87M | $103.4M | $190.9M | -$11.93M | -$406.6M | $122.8M | $93.56M | -$279.4M | -$4.79M | $19.39M |
| Common Stock Issued | -- | -- | -- | -- | -- | -- | -- | $189.7M | $81.99M | -- |
| **Financing Cash Flow** | $116.8M | $92.68M | -$34.97M | -$28.84M | $195.2M | $200.2M | $8.38M | $204.4M | $84.60M | $119K |
| **Net Change in Cash** | -$23.06M | $23.00M | -$62.43M | -$248.3M | $7.48M | $268.9M | -$5.77M | $29.73M | $21.82M | -$29.05M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$40.74M | $22.71M | -$90.05M | -$67.15M | -$61.94M | -$70.87M | $6.08M | -$51.19M |
| Depreciation & Amortization | $3.52M | $3.76M | $3.86M | $3.87M | $3.89M | $3.90M | $3.96M | $4.02M |
| Stock-Based Compensation | $8.12M | $9.05M | $8.62M | $8.38M | $9.00M | $8.65M | $8.54M | $9.54M |
| Change in Receivables | $98.22M | -$96.71M | $18.25M | -$561K | -$6.31M | -$2.36M | $1.57M | $8.13M |
| Change in Payables | -$2.05M | -$5.29M | $349K | -$1.86M | $694K | $2.53M | -$3.65M | $3.04M |
| **Operating Cash Flow** | $38.61M | -$62.24M | -$76.19M | -$52.29M | -$55.96M | -$49.34M | $33.63M | -$31.62M |
| Capital Expenditure | -$194K | -$760K | -$1.24M | -$508K | -$491K | -$391K | -$1.02M | -$1.08M |
| **Free Cash Flow** | $38.41M | -$63.00M | -$77.42M | -$52.80M | -$56.45M | -$49.73M | $32.60M | -$32.70M |
| Purchases of Investments | -$128.9M | $0 | -$9.84M | -$62.81M | -$39.52M | -$211.1M | -$19.16M | -$16.22M |
| **Investing Cash Flow** | -$86.15M | $65.92M | $70.59M | $37.54M | $42.29M | -$140.4M | $44.74M | $40.27M |
| **Financing Cash Flow** | $106.9M | $17.57M | -$13.64M | -$9.58M | -$7.08M | $139.2M | -$5.79M | -$7.74M |
| **Net Change in Cash** | $59.31M | $21.26M | -$19.24M | -$24.34M | -$20.76M | -$50.55M | $72.58M | $909K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -- | 59.7% | 58.8% | 51.6% | 89.0% | 76.9% | 76.6% | 95.6% | 83.6% | 97.9% |
| **Operating Margin** | -94.6% | -280.0% | -297.1% | -233.2% | 34.0% | -77.1% | -422.9% | 40.3% | -730.2% | -1423.8% |
| **Net Profit Margin** | -113.8% | -272.5% | -292.0% | -248.7% | 27.2% | -72.0% | -268.9% | 45.7% | -704.0% | -1372.1% |
| Return on Equity (ROE) | -188.7% | -87.5% | -84.5% | -54.3% | 16.7% | -29.5% | -21.0% | 19.6% | -40.0% | -38.9% |
| Return on Assets (ROA) | -42.8% | -48.7% | -45.9% | -33.6% | 11.5% | -15.7% | -19.0% | 18.4% | -36.8% | -36.5% |
| Current Ratio | 2.38x | 2.69x | 2.57x | 3.19x | 3.98x | 6.52x | 10.25x | 15.24x | 11.64x | 9.66x |
| Quick Ratio | 2.26x | 2.57x | 2.60x | 4.55x | 6.76x | 6.94x | 13.01x | 22.65x | 12.62x | 16.44x |
| Debt to Equity | 0.72x | 0.32x | 0.29x | 0.18x | 0.11x | 0.19x | 0.03x | 0.01x | -- | -- |
| **Revenue Growth (YoY)** | +104.5% | -7.7% | -19.9% | -76.0% | +204.3% | +338.7% | -83.9% | +2002.4% | +126.5% | -39.5% |
| Gross Profit Growth (YoY) | -- | -6.2% | -8.9% | -86.1% | +252.1% | +340.3% | -87.1% | +2305.2% | +93.4% | -40.0% |
| Operating Income Growth (YoY) | -- | -- | -- | -264.3% | -- | -- | -269.1% | -- | -- | -- |
| **Net Income Growth (YoY)** | -- | -- | -- | -319.3% | -- | -- | -194.8% | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -- | -315.9% | -- | -- | -186.3% | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -194.8% | -- | -- | -202.9% | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -276.8% | -- | -- | -230.7% | -- | -- | -- |
| 5Y Revenue / Share Growth | -20.3% | +75.3% | -68.4% | +651.0% | +6278.2% | +401.2% | -58.5% | +149.1% | -- | -- |
| 10Y Revenue / Share Growth | +299.5% | -27.3% | -21.4% | -- | -- | -- | -- | -- | -- | -- |
| 5Y Net Income / Share Growth | -- | -- | -301.5% | -- | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -- | -- | -- | -- | -- | -- | -- | 59.7% |
| **Operating Margin** | -95.7% | -94.1% | -292.3% | -94.6% | -96.0% | -105.7% | -100.4% | -280.0% |
| **Net Profit Margin** | -113.9% | -112.6% | -330.2% | -113.8% | -110.3% | -112.7% | -100.6% | -272.5% |
| Return on Equity (ROE) | -118.4% | -273.7% | -1375.6% | -188.7% | -110.2% | -82.2% | -57.5% | -87.5% |
| Return on Assets (ROA) | -37.6% | -50.8% | -84.8% | -42.8% | -33.9% | -30.2% | -32.1% | -48.7% |
| Current Ratio | 4.74x | 2.86x | 2.62x | 2.38x | 2.66x | 3.13x | 2.93x | 2.69x |
| Quick Ratio | 3.83x | 2.57x | 2.26x | 2.26x | 2.63x | 3.21x | 2.73x | 2.57x |
| Debt to Equity | 0.45x | 0.96x | 3.37x | 0.72x | 0.47x | 0.36x | 0.29x | 0.32x |
| **Revenue Growth (YoY)** | -69.2% | +405.7% | -92.8% | +43.0% | +22.9% | -4.2% | +469.8% | -4.5% |
| Gross Profit Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | +35.7% |
| Operating Income Growth (YoY) | -- | -- | -787.4% | -- | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -- | -- | -1580.4% | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -1533.3% | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -326.5% | -- | -- | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -337.5% | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
